Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FYA2F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,064
Award facts
- Contract value 100% obligated
- $23,064.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,064.24 to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 ml pen auto-injectors. This competitively awarded, firm fixed-price delivery order was executed on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026.
Kesimpta is a disease-modifying therapy used in the treatment of relapsing multiple sclerosis and represents the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal military and veteran healthcare systems through its DLA contract vehicles. As a major pharmaceutical distributor, AmerisourceBergen maintains a critical role in supporting the Defense Health Agency and other federal healthcare programs through its extensive portfolio of brand-name and generic medications, specialty drugs, vaccines, and medical devices. This delivery order exemplifies the company's capability to fulfill federal medical procurement requirements across multiple therapeutic domains while maintaining firm fixed pricing and competitive award standards.
Quick answers
Who was awarded contract SPE2DR26FYA2F?
SPE2DR26FYA2F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FYA2F worth?
The government has obligated $23,064 on SPE2DR26FYA2F.
Is contract SPE2DR26FYA2F an order under another contract?
Yes. SPE2DR26FYA2F is a delivery order under SPE2DR25D6044, an indefinite delivery contract.
Was contract SPE2DR26FYA2F competed?
The extent of competition for SPE2DR26FYA2F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award